Latest News of BMY
Bristol-Myers Squibb Company (BMY): A Buzzing AI Health Stock to Add to Your Portfolio
By Yahoo! Finance |
5 days ago
Discover the top 10 AI health stocks, including Bristol-Myers Squibb Company, amid AI's transformative impact on healthcare and economy. AI is set to revolutionize diagnostics, treatment, and operatio...
Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
By Yahoo! Finance |
1 week ago
The article discusses the importance of dividend achievers in investment strategies, focusing on Bristol-Myers Squibb Company (BMY) as a top performer with strong growth potential and consistent cash ...
BMY Stock Signals Breakout As FDA OKs Schizophrenia Drug
By Investor's Business Daily |
1 week ago
Bristol-Myers Squibb received FDA approval for Cobenfy, a groundbreaking schizophrenia drug that doesn't block dopamine directly. The stock surged as a result....
-
Bristol-Myers Squibb Company (BMY): Among the Dividend Giants with Lowest Short Interest in 2024
By Yahoo! Finance | 2 weeks agoThe article highlights Bristol-Myers Squibb Company's strong dividend history and growth potential amidst challenges faced by short sellers in the market. Despite recent acquisitions and stock drops, ...
-
Investors Should Be Encouraged By Bloomsbury Publishing's (LON:BMY) Returns On Capital
By Yahoo! Finance | 3 weeks agoTo identify a potential multi-bagger, look for businesses with increasing Return on Capital Employed (ROCE) and growing capital employed. Bloomsbury Publishing shows a 20% ROCE, higher than the indust...
-
Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now?
By Yahoo! Finance | 1 month agoBristol-Myers Squibb (NYSE:BMY) is a top beaten-down dividend stock. Despite challenges, dividend stocks remain strong, attracting investors with stable business models and cash flows. BMY offers soli...
-
Bloomsbury Publishing's (LON:BMY) investors will be pleased with their splendid 259% return over the last five years
By Yahoo! Finance | 1 month agoInvesting in stocks can yield gains exceeding 100% or result in a complete loss. Bloomsbury Publishing saw its stock price surge by 214% in five years. Examining EPS growth and shareholder returns is ...
-
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
By Yahoo! Finance | 2 months agoBristol-Myers Squibb Co has shown strong financial performance and innovation in drug development, especially in immuno-oncology. Despite U.S. market dependence and patent challenges, global expansion...
-
Investors in Bristol-Myers Squibb (NYSE:BMY) from three years ago are still down 30%, even after 5.4% gain this past week
By Yahoo! Finance | 2 months agoBristol-Myers Squibb stock has significantly underperformed the market in the last three years, with a 38% decrease in share price. Despite recent improvements, long-term shareholders are still in the...
-
Bloomsbury Publishing Plc (LON:BMY) Shares Could Be 34% Below Their Intrinsic Value Estimate
By Yahoo! Finance | 2 months agoBloomsbury Publishing Plc (LON:BMY) is currently undervalued by 34% according to the DCF model, with an intrinsic value estimate of UK£8.84 per share, compared to the current price of UK£7.1....
-
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%
By Yahoo! Finance | 2 months agoOwnership research and analyst forecasts help understand stock opportunities. Institutional investors hold a significant stake in Bristol-Myers Squibb, influencing the company's direction. Analyzing o...